Reports for APOTEX INC
Company Name APOTEX INC |
||
---|---|---|
Totals |
||
Shortage reports |
3367 |
|
Actual shortage: | 219 (7%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 10 (0%) | |
Resolved: | 3138 (93%) | |
Discontinuation Reports |
365 |
|
To be discontinued: | 24 (7%) | |
Discontinued: | 341 (93%) | |
Reversed: | 0 (0%) | |
Late reports |
144 (4%) |
|
Overdue reports |
68 (28%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-MELOXICAM | 7.5MG | TABLET | Resolved | 2018-08-27 | 2019-05-21 | 59302 |
APO-MELOXICAM | 1.5G | SUSPENSION | Resolved | 2021-04-09 | 2021-05-17 | 137257 |
APO-MELOXICAM | 1.5G | SUSPENSION | Resolved | 2021-04-30 | 2021-05-17 | 138349 |
APO-MELOXICAM | 1.5G | SUSPENSION | Resolved | 2021-12-17 | 2022-03-29 | 151345 |
APO-MELOXICAM | 1.5G | SUSPENSION | Resolved | 2023-02-16 | 2023-04-04 | 185042 |
APO-MELOXICAM | 1.5G | SUSPENSION | Resolved | 2023-04-06 | 2023-07-13 | 188982 |
APO-MELOXICAM | 1.5G | SUSPENSION | Resolved | 2023-05-26 | 2023-07-13 | 193230 |
APO-MELOXICAM | 1.5G | SUSPENSION | Resolved | 2023-06-09 | 2023-07-13 | 194564 |
APO-MELOXICAM | 15MG | TABLET | Resolved | 2017-03-10 | 2017-07-13 | 378 |
APO-MELOXICAM | 1.5G | SUSPENSION | Resolved | 2017-03-11 | 2019-11-25 | 586 |
APO-MELOXICAM | 1.5G | SUSPENSION | Resolved | 2017-03-11 | 2018-05-02 | 589 |
APO-MELOXICAM | 7.5MG | TABLET | Resolved | 2017-05-04 | 2017-10-05 | 8871 |
APO-MELOXICAM | 1.5G | SUSPENSION | Resolved | 2023-09-01 | 2024-02-09 | 203542 |
APO-MELOXICAM | 1.5G | SUSPENSION | Resolved | 2023-09-22 | 2023-12-08 | 204993 |
APO-MELOXICAM | 1.5G | SUSPENSION | Resolved | 2023-11-10 | 2023-12-08 | 209926 |
APO-MEMANTINE | 10MG | TABLET | Resolved | 2022-07-29 | 2022-10-14 | 165723 |
APO-MEMANTINE | 10MG | TABLET | Resolved | 2017-06-28 | 2020-06-03 | 14191 |
APO-MEMANTINE | 10MG | TABLET | Resolved | 2017-03-10 | 2017-04-04 | 381 |
APO-METFORMIN ER | 1000MG | TABLET (EXTENDED-RELEASE) | Resolved | 2022-05-27 | 2022-06-03 | 161442 |
APO-METFORMIN ER | 500MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-08-13 | 2023-10-15 | 201719 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-QUETIAPINE | 25MG | TABLET | Discontinued | 2021-06-25 | 2021-06-25 | 141546 |
APO-QUININE | 200MG | CAPSULE | Discontinued | 2018-09-08 | 2021-05-10 | 60711 |
APO-QUININE | 300MG | CAPSULE | Discontinued | 2018-09-08 | 2021-05-10 | 60714 |
APO-RABEPRAZOLE | 10MG | TABLET (ENTERIC-COATED) | Discontinued | 2018-02-23 | 2019-09-12 | 40805 |
APO-RABEPRAZOLE | 20MG | TABLET (ENTERIC-COATED) | Discontinued | 2018-09-08 | 2018-10-05 | 60717 |
APO-RABEPRAZOLE | 20MG | TABLET (ENTERIC-COATED) | Discontinued | 2019-01-04 | 2019-01-04 | 71201 |
APO-RABEPRAZOLE | 10MG | TABLET (ENTERIC-COATED) | Discontinued | 2019-01-04 | 2019-01-04 | 71204 |
APO-RAMIPRIL | 1.25MG | CAPSULE | Discontinued | 2018-09-08 | 2019-03-29 | 60720 |
APO-RANITIDINE TABLET 150MG | 150MG | TABLET | Discontinued | 2018-09-08 | 2019-02-13 | 60723 |
APO-RANITIDINE TABLET 150MG | 150MG | TABLET | Discontinued | 2018-09-08 | 2018-12-28 | 60726 |
APO-RANITIDINE TABLET 150MG | 150MG | TABLET | Discontinued | 2019-01-02 | 2019-01-09 | 70810 |
APO-RANITIDINE TABLET 300MG | 300MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60729 |
APO-RANITIDINE TABLET 300MG | 300MG | TABLET | To be discontinued | 2018-09-08 | 2018-09-08 | 60732 |
APO-REPAGLINIDE | Discontinued | 2018-09-08 | 2018-09-15 | 60735 | ||
APO-REPAGLINIDE | Discontinued | 2018-09-08 | 2018-09-15 | 60738 | ||
APO-REPAGLINIDE | Discontinued | 2018-09-08 | 2018-09-15 | 60741 | ||
APO-RILUZOLE | 50MG | TABLET | To be discontinued | 2018-09-08 | 2018-09-08 | 60744 |
APO-RISEDRONATE | 35MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60747 |
APO-RISEDRONATE | 35MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64965 |
APO-RISPERIDONE | 3.0MG | TABLET | Discontinued | 2018-09-08 | 2019-06-12 | 60750 |